IP Library Assignment 072828/0564
Patent Assignment
Reel/Frame 072828/0564

Patent Security Agreement

Recorded: 2025-09-03 Pages: 13
Assignors
PRECIGEN, INC.
Executed: 2025-09-03
GENVEC LLC
Executed: 2025-09-03
PRECIGEN ACTOBIO, INC.
Executed: 2025-09-03
EXEMPLAR GENETICS, LLC
Executed: 2025-09-03
Assignee
BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties (77)
Frataxin Expression Constructs
Application: 18/357,565 →
Publication: US US20240000973A1
CD33 Specific Chimeric Antigen Receptors
Application: 18/462,207 →
Publication: US US20240254188A1
Polypeptide Compositions Comprising Spacers
Application: 18/344,421 →
Publication: US US20230414661A1
Method for Integration of Transgenes
Application: 18/426,680 →
Publication: US US20240263183A1
Expression of Novel Cell Tags
Application: 18/953,059 →
Publication: US US20250304930A1
Human Papillomavirus Vaccines and Uses of the Same
Application: 19/261,890 →
Publication: US US20260098063A1
MUC16 Specific Chimeric Antigen Receptors and Uses Thereof
Application: 18/628,575 →
Publication: US US20240368305A1
Ror-1 Specific Chimeric Antigen Receptors and Uses Thereof
Application: 19/077,365 →
Publication: US US20260035432A1
Fusion Constructs and Methods of Using Thereof
Application: 18/058,364 →
Publication: US US20240141045A1
Hepatitis B Vaccines and Uses of the Same
Application: 19/023,657 →
Publication: US US20250223320A1
Fusion Constructs and Methods of Using Thereof
Application: 18/966,676 →
Publication: US US20250325665A1
Electroporation Apparatus and Method
Application: 17/095,028 →
Publication: US US20210139837A1
Human Papilloma Virus Vaccines and Uses of the Same for HPV Associated Diseases
Application: 18/253,624 →
Publication: US US20240173396A1
Chimeric Receptor Therapy
Application: 17/572,618 →
Publication: US US20220220187A1
POLYCISTRONIC miRNA CONSTRUCTS FOR IMMUNE CHECKPOINT INHIBITION
Application: 18/992,243 →
Publication: US US20250388905A1
Human Papillomavirus Vaccines and Uses of the Same
Application: 18/671,275 →
Publication: US US20240390475A1
Novel Adenovirus Vaccine Therapy for the Treatment of Recurrent Respiratory Papillomatosis
Application: 18/671,685 →
Publication: US US20240398926A1
Recombinant Vectors Comprising Polycistronic Expression Cassettes and Methods of Use Thereof
Application: 18/259,985 →
Publication: US US20240316199A1
Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
Patent: 9,102,648 →
Application: 11/841,617 →
Publication: US US20150240244A1
Process of Preparing Chiral Diacylhydrazine Ligands
Patent: 8,884,060 →
Application: 13/309,918 →
Publication: US US20120316066A1
Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
Application: 15/420,229 →
Publication: US US20170204079A1
Crystalline Diacylhydrazine and the Use Thereof
Patent: 8,946,294 →
Application: 13/606,444 →
Publication: US US20130079413A1
Crystalline Diacylhydrazine and the Use Thereof
Application: 15/398,236 →
Publication: US US20170107175A1
Engineered Dendritic Cells and Uses for the Treatment of Cancer
Patent: 9,675,642 →
Application: 13/737,316 →
Publication: US US20130149290A1
Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof
Application: 15/648,623 →
Publication: US US20180002719A1
Mtor Ligands and Polynucleotides Encoding Mtor Ligands
Patent: 7,705,122 →
Application: 11/947,880 →
Publication: US US20080220475A1
Site-specific serine recombinases and methods of their use
Patent: 9,034,650 →
Application: 11/049,552 →
Publication: US US20060172377A1
Synthetic 5'UTRS, Expression Vectors, and Methods for Increasing Transgene Expression
Patent: 8,835,621 →
Application: 12/681,609 →
Publication: US US20100293625A1
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
Patent: 8,715,959 →
Application: 10/468,193 →
Publication: US US20060100416A1
Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System
Patent: 9,163,256 →
Application: 11/841,464 →
Publication: US US20080145935A1
Animal Models of Atherosclerosis
Application: 13/624,967 →
Publication: US US20130203870A1
Animal Models of Duchenne Muscular Dystrophy
Application: 14/164,204 →
Publication: US US20140223589A1
Frataxin Expression Constructs
Application: 15/807,350 →
Publication: US US20180140721A1
Frataxin Expression Constructs
Application: 17/125,449 →
Publication: US US20210177991A1
CD33 Specific Chimeric Antigen Receptors
Application: 15/616,869 →
Publication: US US20180002397A1
Polypeptide Compositions Comprising Spacers
Application: 16/163,233 →
Publication: US US20190111080A1
Modulating Expression of Polypeptides via New Gene Switch Expression Systems
Application: 15/867,500 →
Publication: US US20180291384A1
Modulating Expression of Polypeptides via New Gene Switch Expression Systems
Application: 16/881,871 →
Publication: US US20200283778A1
Expression of Novel Cell Tags
Application: 16/001,759 →
Publication: US US20180362940A1
Expression of Novel Cell Tags
Application: 17/302,514 →
Publication: US US20210324350A1
Expression of Novel Cell Tags
Application: 17/303,970 →
Publication: US US20220064609A1
Method for Propagating Adenoviral Vectors Encoding Inhibitory Gene Products
Patent: 9,388,429 →
Application: 14/288,493 →
Publication: US US20140273228A1
Method for Propagating Adenoviral Vectors Encoding Inhibitory Gene Products
Application: 15/698,259 →
Publication: US US20180223290A1
Methods of Propagating Monkey Adenoviral Vectors
Patent: 9,133,248 →
Application: 13/508,659 →
Publication: US US20120225470A1
Methods of Propagating Monkey Adenoviral Vectors
Patent: 9,586,998 →
Application: 14/817,910 →
Publication: US US20150329834A1
Adenoviral Vector-Based Respiratory Syncytial Virus (Rsv) Vaccine
Patent: 9,580,476 →
Application: 14/349,735 →
Publication: US US20140271711A1
Simian (Gorilla) Adenovirus or Adenoviral Vectors and Methods of Use
Patent: 9,617,560 →
Application: 14/349,470 →
Publication: US US20140314717A1
Simian (Gorilla) Adenovirus or Adenoviral Vectors and Methods of Use
Application: 15/482,991 →
Publication: US US20170211097A1
Simian (Gorilla) Adenovirus or Adenoviral Vectors and Methods of Use
Application: 16/043,501 →
Publication: US US20190055579A1
Simian (Gorilla) Adenovirus or Adenoviral Vectors and Methods of Use
Application: 17/002,064 →
Publication: US US20210040502A1
Affenadenovirus (Gorilla) or Adenoviral Vectors and Methods of Use
Patent: 9,629,906 →
Application: 14/349,426 →
Publication: US US20140248308A1
Affenadenovirus (Gorilla) or Adenoviral Vectors and Methods of Use
Application: 15/492,016 →
Publication: US US20170246318A1
Affenadenovirus (Gorilla) or Adenoviral Vectors and Methods of Use
Application: 16/352,459 →
Publication: US US20190269794A1
Affenadenovirus (Gorilla) or Adenoviral Vectors and Methods of Use
Patent: 9,233,153 →
Application: 14/349,421 →
Publication: US US20140248307A1
Affenadenovirus (Gorilla) or Adenoviral Vectors and Methods of Use
Patent: 9,725,738 →
Application: 14/992,152 →
Publication: US US20160122781A1
Affenadenovirus (Gorilla) or Adenoviral Vectors and Methods of Use
Application: 15/650,289 →
Publication: US US20180066281A1
Affenadenovirus (Gorilla) or Adenoviral Vectors and Methods of Use
Application: 16/282,924 →
Publication: US US20190316152A1
Herpes Simplex Virus Vaccine
Patent: 9,676,824 →
Application: 14/403,397 →
Publication: US US20150140025A1
Herpes Simplex Virus Vaccine
Application: 15/618,740 →
Publication: US US20170275339A1
Modified Serotype 28 Adenoviral Vectors
Patent: 9,790,519 →
Application: 14/403,651 →
Publication: US US20150167018A1
Modified Serotype 28 Adenoviral Vectors
Application: 15/700,279 →
Publication: US US20180100164A1
Adenovectors for Delivery of Therapeutic Genetic Material into T Cells
Application: 16/338,075 →
Publication: US US20190233845A1
Adenoviral Vector-Based Dengue Fever Vaccine
Patent: 8,920,813 →
Application: 13/993,210 →
Publication: US US20130337008A1
Malaria Antigens and Methods of Use
Application: 15/800,975 →
Publication: US US20180153979A1
Malaria Antigens and Methods of Use
Application: 16/008,852 →
Publication: US US20180344833A1
Malaria Antigens and Methods of Use
Application: 16/393,035 →
Publication: US US20190247483A1
Human Papillomavirus Vaccines and Uses of the Same
Application: 16/978,573 →
Publication: US US20210024586A1
Recombinant Adenovirus Vectored Fmdv Vaccines and Uses Thereof
Application: 15/419,418 →
Publication: US US20170216422A1
Recombinant Adenovirus Vectored Fmdv Vaccines and Uses Thereof
Application: 16/250,654 →
Publication: US US20190134183A1
MUC16 Specific Chimeric Antigen Receptors and Uses Thereof
Application: 16/431,193 →
Publication: US US20190375854A1
MUC16 Specific Chimeric Antigen Receptors and Uses Thereof
Application: 17/650,025 →
Publication: US US20220153867A1
MUC16 Specific Chimeric Antigen Receptors and Uses Thereof
Application: 17/650,018 →
Publication: US US20220153866A1
Ror-1 Specific Chimeric Antigen Receptors and Uses Thereof
Application: 17/143,386 →
Publication: US US20210177902A1
Fusion Constructs and Methods of Using Thereof
Application: 16/506,981 →
Publication: US US20200048351A1
Hepatitis B Vaccines and Uses of the Same
Application: 16/978,570 →
Publication: US US20210015911A1
Hepatitis B Vaccines and Uses of the Same
Application: 18/074,302 →
Publication: US US20230279057A1
Fusion Constructs and Methods of Using Thereof
Application: 17/305,577 →
Publication: US US20220023420A1
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Aug 7, 2008
From: RHEOGENE HOLDINGS, INC.
To: RHEOGENE, INC. (DE CORPORATION)
Reel/Frame 021356/0581 →
Assignment of Assignor's Interest Oct 26, 2012
From: HORMANN, ROBERT; SHULMAN, INNA; RODEL, EVA; HILFIKER, ROLF
To: INTREXON CORPORATION
Reel/Frame 029196/0085 →
Merger May 6, 2013
From: NEW RHEOGENE I, LLC; NEW RHEOGENE II, LLC
To: RHEOGENE, INC.
Reel/Frame 030356/0685 →
Assignment of Assignor's Interest Aug 25, 2021
From: BUTMAN, BRYAN; ZHANG, SHUYUAN
To: PRECIGEN, INC.
Reel/Frame 057283/0518 →
Assignment of Assignor's Interest Aug 25, 2021
From: TENSENTRIC
To: PRECIGEN, INC.
Reel/Frame 057283/0805 →
Assignment of Assignor's Interest Aug 25, 2021
From: INSLEE, JUSTIN; SCHNEIDER, ROBERT; KRUGER, KRAIG; ANDREWS, TRAVIS
To: TENSENTRIC
Reel/Frame 057283/0639 →
Assignment of Assignor's Interest Sep 10, 2021
From: SO, VINCENT; GREEN, CHAD
To: DARK HORSE CONSULTING GROUP, INC.
Reel/Frame 057444/0452 →
Assignment of Assignor's Interest Sep 10, 2021
From: DARK HORSE CONSULTING GROUP, INC.
To: PRECIGEN, INC.
Reel/Frame 057444/0499 →
Assignment of Assignor's Interest Mar 22, 2022
From: SABZEVARI, HELEN; BOLINGER, CHERYL G; SHAH, RUTUL R; CHEN, CHANGHUNG
To: PRECIGEN, INC.
Reel/Frame 059335/0929 →
Assignment of Assignor's Interest May 3, 2022
From: REED, THOMAS D.
To: PRECIGEN, INC.
Reel/Frame 059789/0731 →
Assignment of Assignor's Interest May 3, 2022
From: CARSON, JONATHAN
To: PRECIGEN, INC.
Reel/Frame 059789/0755 →
Assignment of Assignor's Interest Jun 30, 2023
From: OLIVARES, SIMON; SINGH, HARJEET; COOPER, LAURENCE JAMES NEIL; HURTON, LENKA VICTORIA
To: ALAUNOS THERAPEUTICS, INC.
Reel/Frame 064128/0632 →
Assignment of Assignor's Interest Jul 12, 2023
From: BROUGH, DOUGLAS E.; ETTYREDDY, DAMODAR R.; YANG, QI; WANG, CHEN
To: PRECIGEN, INC.
Reel/Frame 064257/0929 →
Assignment of Assignor's Interest Jul 24, 2023
From: ROBINSON, GREGORY; PYKETT, MARK; THORN, RICHARD; GRUIS, KIRSTEN
To: AGILIS BIOTHERAPEUTICS
Reel/Frame 064360/0070 →
Assignment of Assignor's Interest Jul 24, 2023
From: SCHAUER, STEPHEN; THOMAS, DARBY
To: INTREXON CORPORATION
Reel/Frame 064359/0769 →
Change of Name Jul 24, 2023
From: INTREXON CORPORATION
To: PRECIGEN, INC.
Reel/Frame 064368/0409 →
Assignment of Assignor's Interest Jul 24, 2023
From: AGILIS BIOTHERAPEUTICS
To: INTREXON CORPORATION
Reel/Frame 064360/0164 →
Assignment of Assignor's Interest Jan 30, 2024
From: SHAH, RUTUL; BOLINGER, CHERYL G.; REED, THOMAS D.
To: INTREXON CORPORATION
Reel/Frame 066295/0791 →
Assignment of Assignor's Interest Aug 9, 2024
From: BROUGH, DOUGLAS E.; ETTYREDDY, DAMODAR R.; YANG, QI; WANG, CHEN
To: PRECIGEN, INC.
Reel/Frame 068235/0810 →
Assignment of Assignor's Interest Aug 19, 2024
From: BROUGH, DOUGLAS E.; BOLINGER, CHERYL G.; YARLAGADDA, RAMYA; KURELLA, VINODHBABU
To: PRECIGEN, INC.
Reel/Frame 068692/0751 →
Assignment of Assignor's Interest Sep 10, 2024
From: ALAUNOS THERAPEUTICS, INC.
To: PRECIGEN, INC.
Reel/Frame 068540/0941 →
Assignment of Assignor's Interest Feb 3, 2025
From: SHAH, RUTUL; BOLINGER, CHERYL
To: PRECIGEN, INC.
Reel/Frame 070091/0106 →